AptarGroup, Inc. (ATR)

AptarGroup's stock was impacted by the release of its fourth-quarter and full-year 2025 results on February 5-6, 2026. The company reported stronger-than-expected revenue for Q4 2025, with sales increasing by 14% to $963 million, leading to a modest increase in the stock price. Despite revenue growth, profitability was affected by product mix and higher operational costs, resulting in a decline in adjusted EBITDA margin and a decrease in net income and EPS. As of January 16, 2026, the stock price was $124.71, a decline of 21.97% from January 21, 2025.

AptarGroup's beauty segment experienced encouraging holiday sales, suggesting a seasonal uplift in demand. However, the company is navigating a decline in demand for emergency medicine products, projected to be a $65 million revenue drag in 2026, with the most pronounced impact expected in the first half of the year.

AptarGroup, Inc. is a global leader in dispensing, dosing, and protection technologies for consumer products and pharmaceutical applications. Headquartered in Crystal Lake, Illinois, it operates in the Healthcare sector, specifically in the Medical Devices & Instruments industry. AptarGroup's business is divided into three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company offers a diverse range of dispensing systems, including pumps, closures, and aerosol valves, and emphasizes sustainability initiatives and advanced drug delivery systems.

AptarGroup has a significant global presence with manufacturing facilities in 20 countries. The company's annual net sales are primarily derived from Europe (49%) and the United States (32%), with a strategic focus on increasing its presence in Asia (11%) and Latin America (8%). Specific locations include cities in France, Germany, Spain, Turkey, Russia, India, Brazil, China, and the United States.

AptarGroup has focused on innovation and strategic growth, contributing positively to its brand reputation. The company reported new product launches in its Pharma and Beauty segments, and has emphasized sustainability initiatives and digital health solutions. No specific events were found that negatively impacted AptarGroup's brand reputation in the past year.

AptarGroup, Inc. has a high level of institutional ownership, with 960 institutional owners and shareholders holding 55.88% of the company's stock. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and State Farm Mutual Automobile Insurance Co. Insider ownership is relatively low at 0.64%.